New MRI technique could sharpen MS diagnosis

NCT ID NCT04705870

Completed Diagnosis Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different MRI scanning methods to see which better detects the 'central vein sign' in the brains of people with multiple sclerosis (MS). The central vein sign is a marker that helps doctors diagnose MS more accurately. Sixty adults with early-stage MS underwent extra MRI sequences during their routine scan. The goal was to compare a standard fast MRI with a newer, higher-resolution version to see if the newer one finds more of these signs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cerebral MRI (device)
What this could lead to: If successful, this could lead to more accurate and faster MRI-based diagnosis of multiple sclerosis.
What could go wrong: This is a small, completed study focused on comparing imaging techniques, not a treatment. Results may not change current practice without larger validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

Hhopital fondation adolphe de rothschild

Paris, Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.